EUCTR2004-000408-41-GB进行中（未招募）1 期
RANDOMIZED, DOUBLE–BLIND, MULTICENTER STUDY TO COMPARE THE SAFETY AND EFFICACY OF VIRAMIDINE TO RIBAVIRIN IN TREATMENT–NAïVE PATIENTS WITH CHRONIC HEPATITIS C
Ribapharm, Inc.0 个研究点目标入组 900 人开始时间: 2005年2月14日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 900
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Treatment–naïve patients with compensated chronic hepatitis C.
- •2. HCV RNA >2000 copies/mL (780 IU/mL) as determined by NGI SuperQuant serum HCV RNA quantification, with a lower limit of detection of 100 copies/mL (39 IU/mL).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Severe neuropsychiatric disorders
- •2. History or clinical manifestations of significant metabolic, hematological, pulmonary, ischemic heart disease, significant or unstable heart disease, gastrointestinal, neurological, renal, urological, endocrine, ophthalmologic disorders including severe retinopathy, or immune mediated disease
- •3. Pregnant or breast-feeding patients
研究者
相似试验
已完成
不适用
Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler´s DiarrheaPER-026-06OPTIMER PHARMACEUTICALS, INC., BIO TRIALS PERU S.A.C.,
已完成
1 期
MULTICENTRIC, DOUBLE-BLIND, RANDOMIZED STUDY TO COMPARE THE SAFETY AND EFFICACY OF TIGECICLINE WITH VANCOMYCIN / AZTREONAM IN THE TREATMENT OF COMPLICATED INFECTIONS OF SKIN AND SKIN STRUCTURE.-L08L08PER-003-03ABORATORIOS WYETH S.A.,
已完成
1 期
MULTICENTRIC, RANDOMIZED, DOUBLE-BLIND STUDY TO COMPARE THE SAFETY AND EFFICACY OF THE ADMINISTRATION OF TIGECICLINE WITH IMIPENEM / CILASTATIN IN THE TREATMENT OF COMPLICATED INTRABDOMINAL INFECTIONS OF INTERNAL PATIENTS-K678 Other disorders of peritoneum in infectious diseases classified elsewhereOther disorders of peritoneum in infectious diseases classified elsewhereK678PER-005-03ABORATORIOS WYETH S.A.,
进行中（未招募）
不适用
RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF THE EFFICACY, TOLERABILITY AND SAFETY OF VALDECOXIB (BEXTRA®)10 MG OD VS. DICLOFENAC SODIUM 50 MG TDS FOR 6 WEEKS IN SUBJECTS WITH OSTEOARTHRITIS OF THE KNEE. - N/AOsteoarthritis of the kneeClassification code 10031161EUCTR2004-001713-34-GBPfizer Limited516
已完成
不适用
A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY TO EVALUATE THE EFFECT OF THE ADDITION OF MONTELUKAST SODIUM OR SALMETEROL XINAFOATE TO INHALED FLUTICASONE IN ASTHMATIC ADULTSPER-016-99MERCK SHARP & DOHME PERÚ S.R.L.,